Jaguar Health (JAGX)
2.28
0.00 (0.00%)
Upcoming Events
Latest Headlines
Jaguar Health's crofelemer shows early benefit in third rare gut disorder
October 21, 2026 9:02 AM - StreetInsider
Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
October 21, 2026 9:01 AM - StreetInsider
Jaguar Health sets ex-dividend date for Series R preferred stock dividend
October 14, 2026 4:16 PM - StreetInsider
Jaguar Health Provides Update Regarding Special Stock Dividend
October 14, 2026 4:15 PM - StreetInsider
Jaguar Health unit presents crofelemer SBS-IF study data at ACG 2026
October 14, 2026 9:03 AM - StreetInsider
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar H
October 14, 2026 9:01 AM - StreetInsider
Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
October 13, 2026 9:01 AM - StreetInsider
Form DEF 14A Jaguar Health, Inc. For: Nov 06
October 8, 2026 4:26 PM - SEC Filing
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
October 6, 2026 9:02 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Sep 30
October 5, 2026 8:45 AM - SEC Filing
Jaguar Health Announces a Special Stock Dividend
October 2, 2026 8:35 PM - StreetInsider
Form PRER14A Jaguar Health, Inc.
September 29, 2026 4:16 PM - SEC Filing
Napo Pharmaceuticals crofelemer study accepted for ACG 2026 meeting
September 29, 2026 6:03 AM - StreetInsider
Preliminary Results of Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer Accepted for Presentation at Annual American College of
September 29, 2026 4:30 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Sep 25
September 28, 2026 7:00 AM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Sep 23
September 25, 2026 6:01 AM - SEC Filing
Form SCHEDULE 13G/A Jaguar Health, Inc. Filed by: Mailman Joshua
September 24, 2026 6:17 PM - SEC Filing
Form 424B5 Jaguar Health, Inc.
September 24, 2026 9:23 AM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Sep 23
September 24, 2026 6:02 AM - SEC Filing
FDA grants Jaguar Health fee waivers for two drugs in fiscal 2027
September 22, 2026 9:06 AM - StreetInsider
Jaguar Health Receives Fee Waivers from FDA
September 22, 2026 9:05 AM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Sep 15
September 21, 2026 4:48 PM - SEC Filing
Form PRE 14A Jaguar Health, Inc. For: Oct 23
September 18, 2026 5:23 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Sep 11
September 15, 2026 1:45 PM - SEC Filing
Form 8-K Jaguar Health, Inc. For: Sep 14
September 15, 2026 9:10 AM - SEC Filing
Jaguar Health announces 1-for-15 reverse stock split on Nasdaq
September 15, 2026 9:01 AM - StreetInsider
Jaguar Health, Inc. Announces Reverse Stock Split
September 15, 2026 9:01 AM - StreetInsider
Jaguar Health MVID trial moves to extension phase ahead of 2027 NDA
September 10, 2026 9:01 AM - StreetInsider
All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failu
September 10, 2026 9:01 AM - StreetInsider
Now Available on Amazon: Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
September 8, 2026 9:01 AM - StreetInsider
Jaguar Health provides crofelemer to infant for compassionate use
September 4, 2026 8:33 AM - StreetInsider
Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
September 4, 2026 8:31 AM - StreetInsider
Jaguar Health launches Neonorm Dog for canine digestive support
August 26, 2026 9:01 AM - StreetInsider
Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
August 26, 2026 9:01 AM - StreetInsider
Form 424B3 Jaguar Health, Inc.
August 21, 2026 3:01 PM - SEC Filing
Jaguar Health (JAGX) Tops Q2 EPS by 3647c
August 19, 2026 5:25 PM - StreetInsider
Form 8-K Jaguar Health, Inc. For: Aug 19
August 19, 2026 4:15 PM - SEC Filing
Jaguar Health Reports Second Quarter 2026 Financials
August 19, 2026 4:00 PM - StreetInsider
Form 10-Q Jaguar Health, Inc. For: Jun 30
August 19, 2026 1:18 PM - SEC Filing
Jaguar Health to Hold Investor Webcast August 19 Regarding Q2 2026 Financials & Corporate Updates
August 18, 2026 9:00 AM - StreetInsider
Form EFFECT Jaguar Health, Inc.
August 17, 2026 6:15 AM - SEC Filing
Form NT 10-Q Jaguar Health, Inc. For: Jun 30
August 14, 2026 5:25 PM - SEC Filing
Form POS AM Jaguar Health, Inc.
August 11, 2026 8:01 AM - SEC Filing
Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
August 5, 2026 9:01 AM - StreetInsider
Form DEF 14A Jaguar Health, Inc. For: Sep 04
August 3, 2026 4:37 PM - SEC Filing
Jaguar Health Reports Positive Consumer and Veterinary Market Research Findings Supporting Commercial Opportunity for Neonorm Dog
July 28, 2026 9:01 AM - StreetInsider
Form 424B3 Jaguar Health, Inc.
July 27, 2026 8:01 AM - SEC Filing
Form 424B3 Jaguar Health, Inc.
July 27, 2026 8:00 AM - SEC Filing
Form EFFECT Jaguar Health, Inc.
July 27, 2026 6:03 AM - SEC Filing
Form EFFECT Jaguar Health, Inc.
July 27, 2026 6:03 AM - SEC Filing
Form PRE 14A Jaguar Health, Inc. For: Sep 04
July 24, 2026 4:16 PM - SEC Filing
Jaguar Health (JAGX) files for 41M share offering by selling stockholders
July 24, 2026 2:01 PM - StreetInsider
Form S-1/A Jaguar Health, Inc.
July 24, 2026 1:59 PM - SEC Filing
Full Article List
